drugset / Trial / NCT01748799
Fixed or Self-Titrated Dosages of Sativex on Cannabis Users
Completed
16 enrolled
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR) · collab
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to to demonstrate the feasibility and tolerability of the use of Sativex in cannabis dependent individuals and to assess the effects of fixed or self titrated dosages of SATIVEX® (Δ9-tetrahydrocannabinol /cannabidiol combination in a buccal spray) on withdrawal symptoms, craving scores and cannabis consumption during the study period.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nabiximols | Other / unclassified | 108 mg | Other |